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Background
This study investigated the safety profile and potential
“therapeutic” effect of intravenous ultrasmall superpara-
magnetic iron-oxide (USPIO)-based iron administration
regarding infarct healing in patients with ST-elevation
myocardial infarction (STEMI).
Methods
Seventeen study patients (IRON, 54 ± 9 yrs, 88% male)
and 22 matched controls (CONTROL, 57 ± 9 yrs, 77%
male) both with primary reperfused STEMI underwent
multi-parametric CMR studies in the first week and
three months after acute MI. Only IRON patients
received a single intravenous bolus of 510 mg elemental
iron as ferumoxytol (FerahemeTM) within four days
following acute MI.
Results
Three months after study inclusion, all patients were alive
and there were no adverse cardiac events. Significant
improvement in left ventricular (LV) ejection fraction
(IRON: 53 ± 10% to 59 ± 9%, p = 0.002; CONTROL:
54 ± 6% to 57 ± 10%, p = 0.005) as well as shrinkage of
infarct size were seen in both groups at follow-up. There
was a more pronounced decrease in infarct size in the
IRON group (IRON: -10.3 ± 5.4% vs. CONTROL: -7.0 ±
8.4%, p = 0.050) in addition to a significant decrease in
both endocardial extent and prevalence of transmural
infarctions in IRON but not in CONTROL patients. A
significant decrease in LV end systolic volume was only
seen in the IRON group (71 ± 25 mL to 59 ± 25 mL,
p = 0.002).
Conclusions
Intravenous iron administration in acute STEMI patients
is associated with both improved infarct healing and bene-
ficial global left ventricular remodelling (compared to
matched controls). These findings together with the good
safety profile make USPIO-based iron administration a
promising future candidate as a “diagnostic” and “thera-
peutic” adjunctive solution in acute MI management.
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